$ONVO Up to date company activities and other impo
Post# of 102170
Posted On: 11/20/2013 9:33:45 PM
$ONVO Up to date company activities and other important information about $ONVO
$ONVO
DD Notes ~ http://www.ddnotesmaker.com/ONVO
##### recent news/filings ~ source: finance.yahoo.com
Wed, 20 Nov 2013 21:57:15 GMT ~ ORGANOVO HOLDINGS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/131120/onvo8-k.html
*********************************************************
Wed, 20 Nov 2013 18:38:22 GMT ~ 3D Printing Stocks Pummeled for a Second Straight Day
- Every one of the 3D printing stocks we follow got pounded on Tuesday and apparently the beatings will continue until morale improves. Wednesday trading has the stocks down in the early afternoon by just ...
read full: http://finance.yahoo.com/news/3d-printing-sto...22205.html
*********************************************************
Wed, 20 Nov 2013 14:08:41 GMT ~ Organovo At The Mercy Of The Media
- Organovo ( ONVO ) has gained tremendous attention in the market over the past year. The stock began 2013 at below $3.00 but recently rose as high at $13.65. In October, the stock was trading around $5.50, ...
read full: http://seekingalpha.com/article/1851531-organ...urce=yahoo
*********************************************************
Wed, 20 Nov 2013 14:07:48 GMT ~ InPlay: Organovo provides guidance on topics to be discussed at an upcoming investor conference on Dec 5, 2013; company plans to launch an initial 3D liver tissue assay product in 2014
read full: http://finance.yahoo.com/mp#onvo
*********************************************************
Wed, 20 Nov 2013 14:05:00 GMT ~ Organovo Provides Guidance on Upcoming Retail Investor Conference
- SAN DIEGO, Nov. 20, 2013 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, today provided guidance on topics to be discussed at an upcoming Retail Investor Conference on December 5, 2013. Product pipeline and revenue potential: As described previously in the company's presentations and investor communications, including the freely available Retail Investor Conference from September 12, 2013, the company plans to launch an initial 3D liver tissue assay product in 2014, followed by a series of additional tissue assay products. Based on market research, Organovo believes that each of the product opportunities it has identified can grow into the tens of millions in annual revenue and has a $100M+ addressable market, with an overall market opportunity of $500M across all tissue products by 2018. Beyond this market opportunity, defined by sales of current cell based models, also lies the opportunity to develop products and services for the multibillion dollar animal preclinical testing market for pharmaceutical, cosmetic, and environmental industries.
read full: http://finance.yahoo.com/news/organovo-provid...00862.html
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=ONVO&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=ONVO&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ONVO/company-info
Ticker: $ONVO
OTC Market Place: Not Available
CIK code: 0001497253
Company name: Organovo Holdings, Inc.
Company website: http://www.organovo.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/ONVO/filings
Latest financials: http://www.otcmarkets.com/stock/ONVO/financials
Latest news: http://www.otcmarkets.com/stock/ONVO/news - http://finance.yahoo.com/q/h?s=ONVO+Headlines
Major holdings: http://data.cnbc.com/quotes/ONVO/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=ONVO+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/ONVO.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=ONVO
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Organovo+Holdings%...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...ngs%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.organovo.com
Alexa: http://www.alexa.com/siteinfo/http://www.organovo.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.organovo.com
http://www.pennystocktweets.com/stocks/profile/ONVO
##### last known share structure ~ source: otcmarkets.com
Market Value: $475,873,969 a/o Nov 19, 2013
Shares Outstanding: 76,507,069 a/o Aug 07, 2013
Float: 50,000,000 a/o Mar 31, 2013
Authorized Shares: 150,000,000 a/o Feb 03, 2012
Par Value: 0.001
##### business description ~ source: otcmarkets.com
Organovo designs and creates functional human tissues using a proprietary three dimensional bioprinting technology. The Company focuses on developing a range of human tissues and disease models for medical research and therapeutic applications. The Company's NovoGen? three-dimensional bioprinting technology employs a specialized automated platform that works across all tissue and cell types. Organovo?s bioprinter was named one of the ?Best Inventions of 2010? by TIME Magazine and Organovo has... read more: http://www.otcmarkets.com/stock/ONVO/company-info
DD Notes ~ http://www.ddnotesmaker.com/ONVO
$ONVO
DD Notes ~ http://www.ddnotesmaker.com/ONVO
##### recent news/filings ~ source: finance.yahoo.com
Wed, 20 Nov 2013 21:57:15 GMT ~ ORGANOVO HOLDINGS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/131120/onvo8-k.html
*********************************************************
Wed, 20 Nov 2013 18:38:22 GMT ~ 3D Printing Stocks Pummeled for a Second Straight Day
- Every one of the 3D printing stocks we follow got pounded on Tuesday and apparently the beatings will continue until morale improves. Wednesday trading has the stocks down in the early afternoon by just ...
read full: http://finance.yahoo.com/news/3d-printing-sto...22205.html
*********************************************************
Wed, 20 Nov 2013 14:08:41 GMT ~ Organovo At The Mercy Of The Media
- Organovo ( ONVO ) has gained tremendous attention in the market over the past year. The stock began 2013 at below $3.00 but recently rose as high at $13.65. In October, the stock was trading around $5.50, ...
read full: http://seekingalpha.com/article/1851531-organ...urce=yahoo
*********************************************************
Wed, 20 Nov 2013 14:07:48 GMT ~ InPlay: Organovo provides guidance on topics to be discussed at an upcoming investor conference on Dec 5, 2013; company plans to launch an initial 3D liver tissue assay product in 2014
read full: http://finance.yahoo.com/mp#onvo
*********************************************************
Wed, 20 Nov 2013 14:05:00 GMT ~ Organovo Provides Guidance on Upcoming Retail Investor Conference
- SAN DIEGO, Nov. 20, 2013 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, today provided guidance on topics to be discussed at an upcoming Retail Investor Conference on December 5, 2013. Product pipeline and revenue potential: As described previously in the company's presentations and investor communications, including the freely available Retail Investor Conference from September 12, 2013, the company plans to launch an initial 3D liver tissue assay product in 2014, followed by a series of additional tissue assay products. Based on market research, Organovo believes that each of the product opportunities it has identified can grow into the tens of millions in annual revenue and has a $100M+ addressable market, with an overall market opportunity of $500M across all tissue products by 2018. Beyond this market opportunity, defined by sales of current cell based models, also lies the opportunity to develop products and services for the multibillion dollar animal preclinical testing market for pharmaceutical, cosmetic, and environmental industries.
read full: http://finance.yahoo.com/news/organovo-provid...00862.html
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=ONVO&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=ONVO&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ONVO/company-info
Ticker: $ONVO
OTC Market Place: Not Available
CIK code: 0001497253
Company name: Organovo Holdings, Inc.
Company website: http://www.organovo.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/ONVO/filings
Latest financials: http://www.otcmarkets.com/stock/ONVO/financials
Latest news: http://www.otcmarkets.com/stock/ONVO/news - http://finance.yahoo.com/q/h?s=ONVO+Headlines
Major holdings: http://data.cnbc.com/quotes/ONVO/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=ONVO+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/ONVO.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=ONVO
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Organovo+Holdings%...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...ngs%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.organovo.com
Alexa: http://www.alexa.com/siteinfo/http://www.organovo.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.organovo.com
http://www.pennystocktweets.com/stocks/profile/ONVO
##### last known share structure ~ source: otcmarkets.com
Market Value: $475,873,969 a/o Nov 19, 2013
Shares Outstanding: 76,507,069 a/o Aug 07, 2013
Float: 50,000,000 a/o Mar 31, 2013
Authorized Shares: 150,000,000 a/o Feb 03, 2012
Par Value: 0.001
##### business description ~ source: otcmarkets.com
Organovo designs and creates functional human tissues using a proprietary three dimensional bioprinting technology. The Company focuses on developing a range of human tissues and disease models for medical research and therapeutic applications. The Company's NovoGen? three-dimensional bioprinting technology employs a specialized automated platform that works across all tissue and cell types. Organovo?s bioprinter was named one of the ?Best Inventions of 2010? by TIME Magazine and Organovo has... read more: http://www.otcmarkets.com/stock/ONVO/company-info
DD Notes ~ http://www.ddnotesmaker.com/ONVO
(0)
(0)